查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1574942

藥物製劑市場，按劑型、適應症、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Drug Formulation Market, By Dosage Form, By Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年藥物製劑市場規模為1,759,023.43百萬美元，2024年至2032年複合年成長率為6.01%。

藥物製劑市場-市場動態

對個人化醫療和標靶治療的需求不斷成長推動成長

對個人化醫療和標靶治療的需求不斷成長正在推動藥物製劑市場的成長。個人化醫療根據患者的個別需求客製化治療方案，提高治療效果和效率。根據美國國立衛生研究院 (NIH) 的數據，超過 1,800 項活躍的臨床試驗正在關注個人化治療。

這一轉變凸顯了為不同患者群體制定量身定做治療方案的重要性。教育機構也透過研究新配方和治療策略做出貢獻。隨著醫療保健的發展，對個人化方法的重視可能會擴大，這將使患者和藥物製劑產業受益。

藥物製劑市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 6.01% 左右的複合年成長率成長

根據劑型細分，預計口服製劑將在 2023 年顯示最大的市場佔有率

依適應症細分，2023年傳染病為主導類型

根據最終用戶細分，大型製藥公司是 2023 年的領先類型

按地區分類，北美是 2023 年的主要收入來源

藥物製劑市場-細分分析：

全球藥物製劑市場根據劑型、適應症、最終用戶和地區進行細分。

依劑型，市場分為三類：口服製劑、腸胃外製劑、外用製劑及吸入製劑。口服製劑是最突出的部分。此類別包括片劑和膠囊等各種形式，由於其方便和易於服用而被廣泛使用。其中，片劑，尤其是速釋片劑，因其生產簡單且保存期限長而廣受歡迎。口服製劑因其有效性和舒適性而受到患者和醫療保健提供者的青睞，使其成為市場上的主導選擇。

根據適應症，市場分為兩類：傳染病、癌症、心血管疾病、糖尿病、呼吸系統疾病、中樞神經系統疾病等。傳染病是最突出的部分。這主要是由於對有效治療和疫苗的持續需求，特別是最近的全球健康危機（如 COVID-19 大流行）。由於醫療保健系統專注於預防和治療感染，對抗病毒和抗生素藥物的需求仍然很高。此外，該領域新療法的快速發展推動了創新和投資，使傳染病成為藥物配方的主要焦點。

藥物製劑市場-地理洞察

北美藥物製劑市場非常重要且成長迅速。美國是該市場最大的部分，許多製藥公司都在開發新藥。這些公司專注於創造安全有效的藥物配方來治療各種健康問題。技術和研究的進步正在幫助改進藥​​物輸送方法。加拿大也透過支持醫療保健領域的研究和創新做出貢獻。此外，嚴格的法規確保了藥物配方的高品質標準。總體而言，北美在塑造藥物製劑市場的未來方面發揮著至關重要的作用。

藥物製劑市場-競爭格局：

藥物製劑市場競爭激烈，輝瑞、強生和羅氏等主要參與者處於領先地位。這些公司大力投資研發，以創造新的有效藥物。默克公司和百時美施貴寶也是重要的競爭對手，專注於創新療法。葛蘭素史克和諾華憑藉其強大的產品組合和全球影響力做出了貢獻。此外，艾伯維（AbbVie）和安進（Amgen）等公司以其特種藥物而聞名。在技​​術進步和不斷變化的醫療保健需求的推動下，市場不斷發展。這項競賽促進創新，有助於為患者提供更好的治療方法。

最新進展：

2024 年 9 月，賽諾菲、RadioMedix 和 Orano Med 宣布達成針對罕見癌症的下一代放射性配體治療的許可協議。此次合作的重點是為患有這些特定病症的患者推進創新療法。

20224 年 5 月，諾華同意收購 Mariana Oncology，擴大放射配體治療產品線。這項策略性措施增強了諾華開發標靶癌症治療的能力。

目錄

第 1 章：藥物製劑市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按劑型分類的藥物製劑市場片段
    • 以適應症分類的藥物製劑市場片段
    • 最終使用者的藥物製劑市場片段
    • 按國家/地區分類的藥物製劑市場摘要
    • 按地區分類的藥物製劑市場片段
  • 競爭洞察

第 3 章：藥物製劑主要市場趨勢

  • 藥物製劑市場促進因素
    • 市場促進因素的影響分析
  • 藥物製劑市場限制
    • 市場限制影響分析
  • 藥物製劑市場機會
  • 藥物製劑市場未來趨勢

第 4 章：藥物製劑產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：藥物製劑市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：藥物製劑市場格局

  • 2023 年藥物製劑市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：藥物製劑市場 - 按劑型

  • 概述
    • 按劑型分類的細分市場佔有率分析
    • 口服製劑
      • 平板電腦
      • 立即發布
      • 修改版本
      • 咀嚼片
      • 發泡錠
      • 膠囊
      • 硬明膠膠囊
      • 軟膠囊
      • 其他
      • 粉末和顆粒
      • 錠劑和錠劑
      • 軟糖
      • 其他
    • 腸胃外製劑
      • 解決方案
      • 暫停
      • 注射或輸注用乳劑
      • 注射或輸注用粉劑
      • 用於注射植入物的凝膠
    • 外用製劑
      • 膏體
      • 藥膏和油
      • 霜劑、乳液和泡沫。
      • 凝膠劑、酊劑和粉末
      • 噴霧劑和貼劑
    • 吸入製劑
      • 加壓定量吸入器
      • 乾粉吸入器 (DPI)
      • 噴霧器

第 8 章：藥物製劑市場 - 按適應症

  • 概述
    • 按指標分類的細分市場佔有率分析
    • 傳染病
    • 癌症
    • 心血管疾病
    • 糖尿病
    • 呼吸系統疾病
    • 中樞神經系統疾病
    • 其他

第 9 章：藥物製劑市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 大型製藥公司
    • 中小型製藥公司
    • 生技公司

第 10 章：藥物製劑市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美藥物製劑主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模與預測（按劑型）
    • 北美市場規模和預測（按指標）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲藥物製劑主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按劑型）
    • 歐洲市場規模與預測（按指標）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區藥物製劑主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按劑型）
    • 亞太地區市場規模與預測（依指標）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲藥物製劑主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按劑型）
    • 拉丁美洲市場規模與預測（按指標）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲藥物製劑主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按劑型）
    • 中東和非洲市場規模及預測（依指標）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 藥物製劑產業

  • 競爭儀表板
  • 公司簡介
    • Pfizer
    • Johnson & Johnson
    • Roche
    • Merck & Co.
    • Bristol-Myers Squibb
    • GSK (GlaxoSmithKline)
    • Novartis
    • AbbVie
    • Sanofi
    • Amgen
    • AstraZeneca
    • Bayer
    • Teva Pharmaceutical Industries
    • Mylan
    • Celgene

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3941

REPORT HIGHLIGHT

Drug Formulation Market size was valued at USD 1,759,023.43 Million in 2023, expanding at a CAGR of 6.01% from 2024 to 2032.

The drug formulation market involves the development and production of medications in various forms, like tablets, capsules, and injections. It focuses on combining active ingredients with other substances to create effective and safe drugs. This market plays a crucial role in healthcare by ensuring that medicines can deliver the right dosage and work effectively in the body. Companies in this market conduct research to improve existing drugs and develop new ones. The goal is to provide better treatments for various diseases and conditions. Overall, the drug formulation market is essential for advancing medicine and improving patient care.

Drug Formulation Market- Market Dynamics

Rising demand for personalized medicine and targeted therapies drives growth

Rising demand for personalized medicine and targeted therapies is driving growth in the drug formulation market. Personalized medicine tailors' treatments to individual patient needs, improving outcomes and efficiency. According to the National Institutes of Health (NIH), over 1,800 active clinical trials are focusing on personalized therapies.

This shift highlights the importance of creating tailored treatments for various patient groups. Educational institutions also contribute by researching new formulations and treatment strategies. As healthcare evolves, the emphasis on personalized approaches is likely to expand, benefiting both patients and the drug formulation industry.

Drug Formulation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.01% over the forecast period (2024-2032)

Based on Dosage Form segmentation, Oral formulations was predicted to show maximum market share in the year 2023

Based on Indication segmentation, Infectious Diseases was the leading type in 2023

Based on End User segmentation, Big Pharma Companies was the leading type in 2023

Based on Region, North America was the leading revenue generator in 2023

Drug Formulation Market- Segmentation Analysis:

The Global Drug Formulation Market is segmented based on Dosage Form, Indication, End User, and Region.

The market is divided into three categories based on Dosage Form: Oral formulations, Parenteral formulations, Topical formulations, and Inhalation formulations. Oral formulations are the most prominent segment. This category includes various forms like tablets and capsules, which are widely used due to their convenience and ease of administration. Among these, tablets, especially immediate-release ones, are highly popular because they are simple to produce and have a long shelf life. Oral formulations are preferred by both patients and healthcare providers for their effectiveness and comfort, making them the dominant choice in the market.

The market is divided into two categories based on Indication: Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, and Others. Infectious diseases represent the most prominent segment. This is largely due to the ongoing need for effective treatments and vaccines, especially highlighted by recent global health crises like the COVID-19 pandemic. The demand for antiviral and antibiotic drugs remains high as healthcare systems focus on preventing and treating infections. Additionally, the rapid development of new therapies in this area drives innovation and investment, making infectious diseases a dominant focus in drug formulation.

Drug Formulation Market- Geographical Insights

The North American drug formulation market is very important and is growing quickly. The United States is the largest part of this market, with many pharmaceutical companies developing new medicines. These companies focus on creating safe and effective drug formulations to treat various health issues. Advances in technology and research are helping improve drug delivery methods. Canada is also contributing by supporting research and innovation in the healthcare sector. Additionally, strict regulations ensure high-quality standards for drug formulations. Overall, North America plays a crucial role in shaping the future of the drug formulation market.

Drug Formulation Market- Competitive Landscape:

The drug formulation market is competitive, with major players like Pfizer, Johnson & Johnson, and Roche leading the way. These companies invest heavily in research and development to create new and effective medications. Merck & Co. and Bristol-Myers Squibb are also significant competitors, focusing on innovative therapies. GSK and Novartis contribute with their strong product portfolios and global reach. Additionally, companies like AbbVie and Amgen are known for their specialty drugs. The market is constantly evolving, driven by advancements in technology and changing healthcare needs. This competition fosters innovation and helps bring better treatments to patients.

Recent Developments:

In September 2024, Sanofi, RadioMedix, and Orano Med announced a licensing agreement for a next-generation radioligand treatment aimed at rare cancers. This collaboration focuses on advancing innovative therapies for patients with these specific conditions.

In May 20224 Novartis has agreed to acquire Mariana Oncology, boosting its radioligand therapy pipeline. This strategic move enhances Novartis's capabilities in developing targeted cancer treatments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DRUG FORMULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Pfizer
  • Johnson & Johnson
  • Roche
  • Merck & Co.
  • Bristol-Myers Squibb
  • GSK (GlaxoSmithKline)
  • Novartis
  • AbbVie
  • Sanofi
  • Amgen
  • AstraZeneca
  • Bayer
  • Teva Pharmaceutical Industries
  • Mylan
  • Celgene

GLOBAL DRUG FORMULATION MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

  • Oral formulations
  • Tablets
  • Immediate Release
  • Modified Release
  • Chewable
  • Effervescent
  • Capsules
  • Hard Gelatine Capsules
  • Soft gel Capsules
  • Others
  • Powders & Granules
  • Lozenges & Pastilles
  • Gummies
  • Others
  • Parenteral formulations
  • Solutions
  • Suspensions
  • Emulsions for injection or infusion
  • Powders for injection or infusion
  • Gels for injection implants
  • Topical formulations
  • Pastes
  • Ointments and oils
  • Creams, lotions, and foams.
  • Gels, tinctures, and powders
  • Sprays and patches
  • Inhalation formulations
  • Pressurized Metered Dose Inhaler
  • Dry Powder Inhaler (DPI)
  • Nebulizer

GLOBAL DRUG FORMULATION MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Others

GLOBAL DRUG FORMULATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Big Pharma Companies
  • Small & Medium Size Pharma Companies
  • Biotech Companies

GLOBAL DRUG FORMULATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Drug Formulation Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Drug Formulation Market Snippet by Dosage Form
    • 2.1.2. Drug Formulation Market Snippet by Indication
    • 2.1.3. Drug Formulation Market Snippet by End User
    • 2.1.4. Drug Formulation Market Snippet by Country
    • 2.1.5. Drug Formulation Market Snippet by Region
  • 2.2. Competitive Insights

3. Drug Formulation Key Market Trends

  • 3.1. Drug Formulation Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Drug Formulation Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Drug Formulation Market Opportunities
  • 3.4. Drug Formulation Market Future Trends

4. Drug Formulation Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Drug Formulation Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Drug Formulation Market Landscape

  • 6.1. Drug Formulation Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Drug Formulation Market - By Dosage Form

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
    • 7.1.2. Oral formulations
      • 7.1.2.1. Tablets
      • 7.1.2.1.1. Immediate Release
      • 7.1.2.1.2. Modified Release
      • 7.1.2.1.3. Chewable
      • 7.1.2.1.4. Effervescent
      • 7.1.2.2. Capsules
      • 7.1.2.2.1. Hard Gelatine Capsules
      • 7.1.2.2.2. Soft gel Capsules
      • 7.1.2.2.3. Others
      • 7.1.2.3. Powders & Granules
      • 7.1.2.4. Lozenges & Pastilles
      • 7.1.2.5. Gummies
      • 7.1.2.6. Others
    • 7.1.3. Parenteral formulations
      • 7.1.3.1. Solutions
      • 7.1.3.2. Suspensions
      • 7.1.3.3. Emulsions for injection or infusion
      • 7.1.3.4. Powders for injection or infusion
      • 7.1.3.5. Gels for injection implants
    • 7.1.4. Topical formulations
      • 7.1.4.1. Pastes
      • 7.1.4.2. Ointments and oils
      • 7.1.4.3. Creams, lotions, and foams.
      • 7.1.4.4. Gels, tinctures, and powders
      • 7.1.4.5. Sprays and patches
    • 7.1.5. Inhalation formulations
      • 7.1.5.1. Pressurized Metered Dose Inhaler
      • 7.1.5.2. Dry Powder Inhaler (DPI)
      • 7.1.5.3. Nebulizer

8. Drug Formulation Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 8.1.2. Infectious Diseases
    • 8.1.3. Cancer
    • 8.1.4. Cardiovascular Diseases
    • 8.1.5. Diabetes
    • 8.1.6. Respiratory Diseases
    • 8.1.7. Central Nervous System Disorders
    • 8.1.8. Others

9. Drug Formulation Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Big Pharma Companies
    • 9.1.3. Small & Medium Size Pharma Companies
    • 9.1.4. Biotech Companies

10. Drug Formulation Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Drug Formulation Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Drug Formulation Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Drug Formulation Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Drug Formulation Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Drug Formulation Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Drug Formulation Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer
    • 11.2.2. Johnson & Johnson
    • 11.2.3. Roche
    • 11.2.4. Merck & Co.
    • 11.2.5. Bristol-Myers Squibb
    • 11.2.6. GSK (GlaxoSmithKline)
    • 11.2.7. Novartis
    • 11.2.8. AbbVie
    • 11.2.9. Sanofi
    • 11.2.10. Amgen
    • 11.2.11. AstraZeneca
    • 11.2.12. Bayer
    • 11.2.13. Teva Pharmaceutical Industries
    • 11.2.14. Mylan
    • 11.2.15. Celgene

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us